Recommendation for prenatal screening for congenital toxoplasmosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 19, Issue 4, 2000, Pages 324-325

  Munoz C ^a   Izquierdo, C ^a   Parra, J ^a   Ginovart, G ^a   Margall, N ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FOLINIC ACID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ADULT; AMNIOCENTESIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONGENITAL TOXOPLASMOSIS; CORDOCENTESIS; FEMALE; FETUS ECHOGRAPHY; HUMAN; MATERNAL BLOOD; NOTE; POLYMERASE CHAIN REACTION; PREGNANCY TERMINATION; PRENATAL SCREENING; PRIORITY JOURNAL; TOXOPLASMA GONDII;

EID: 0034057601     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050486     Document Type: Note

References (5)

1. 1. Wong SY, Remington JS: Toxoplasmosis in pregnancy. Clinical Infectious Diseases (1994) 18:853-862
2. 2. Thulliez P: Screening programme for congenital toxoplasmosis in France. Scandinavian Journal of Infectious Diseases (1992) Supplement 84:43-45
3. 3. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R: Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 353:1829-1833
4. 4. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Norgaard-Pedersen B, Petersen E, and the Danish Congenital Toxoplasmosis Study Group: Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet (1999) 353:1834-1837)
5. 5. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E: Classification system and case definitions of Toxoplasma gondii infection in immun-competent pregnant women and their congenitally infected offspring. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:799-805